SignatureFD’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.9K | Sell |
229
-100
| -30% | -$10.4K | ﹤0.01% | 1965 |
|
|
2025
Q1 | $38.4K | Hold |
329
| – | – | ﹤0.01% | 1722 |
|
|
2024
Q4 | $27.8K | Hold |
329
| – | – | ﹤0.01% | 1888 |
|
|
2024
Q3 | $29.6K | Buy |
329
+16
| +5% | +$1.44K | ﹤0.01% | 1847 |
|
|
2024
Q2 | $25.2K | Hold |
313
| – | – | ﹤0.01% | 1842 |
|
|
2024
Q1 | $25K | Buy |
313
+240
| +329% | +$19.2K | ﹤0.01% | 1881 |
|
|
2023
Q4 | $5.81K | Sell |
73
-64
| -47% | -$5.09K | ﹤0.01% | 2449 |
|
|
2023
Q3 | $9.58K | Buy |
137
+64
| +88% | +$4.47K | ﹤0.01% | 2226 |
|
|
2023
Q2 | $5.25K | Sell |
73
-20
| -22% | -$1.44K | ﹤0.01% | 2495 |
|
|
2023
Q1 | $5.74K | Sell |
93
-634
| -87% | -$39.1K | ﹤0.01% | 2454 |
|
|
2022
Q4 | $56.1K | Buy |
727
+627
| +627% | +$48.4K | ﹤0.01% | 1301 |
|
|
2022
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 2489 |
|
|
2022
Q2 | $4K | Sell |
100
-27
| -21% | -$1.08K | ﹤0.01% | 2490 |
|
|
2022
Q1 | $5K | Sell |
127
-451
| -78% | -$17.8K | ﹤0.01% | 2452 |
|
|
2021
Q4 | $22K | Buy |
578
+320
| +124% | +$12.2K | ﹤0.01% | 1734 |
|
|
2021
Q3 | $9K | Buy |
258
+166
| +180% | +$5.79K | ﹤0.01% | 2097 |
|
|
2021
Q2 | $6K | Buy |
92
+15
| +19% | +$978 | ﹤0.01% | 2177 |
|
|
2021
Q1 | $4K | Buy |
77
+62
| +413% | +$3.22K | ﹤0.01% | 2200 |
|
|
2020
Q4 | $1K | Buy |
15
+2
| +15% | +$133 | ﹤0.01% | 2377 |
|
|
2020
Q3 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 2354 |
|